1. Home
  2. LUNG vs BYON Comparison

LUNG vs BYON Comparison

Compare LUNG & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • BYON
  • Stock Information
  • Founded
  • LUNG 1995
  • BYON 1997
  • Country
  • LUNG United States
  • BYON United States
  • Employees
  • LUNG N/A
  • BYON N/A
  • Industry
  • LUNG Industrial Specialties
  • BYON Catalog/Specialty Distribution
  • Sector
  • LUNG Health Care
  • BYON Consumer Discretionary
  • Exchange
  • LUNG Nasdaq
  • BYON Nasdaq
  • Market Cap
  • LUNG 256.3M
  • BYON 254.3M
  • IPO Year
  • LUNG 2020
  • BYON N/A
  • Fundamental
  • Price
  • LUNG $6.36
  • BYON $6.26
  • Analyst Decision
  • LUNG Buy
  • BYON Buy
  • Analyst Count
  • LUNG 6
  • BYON 10
  • Target Price
  • LUNG $11.92
  • BYON $17.00
  • AVG Volume (30 Days)
  • LUNG 214.3K
  • BYON 2.6M
  • Earning Date
  • LUNG 02-19-2025
  • BYON 02-18-2025
  • Dividend Yield
  • LUNG N/A
  • BYON N/A
  • EPS Growth
  • LUNG N/A
  • BYON N/A
  • EPS
  • LUNG N/A
  • BYON N/A
  • Revenue
  • LUNG $79,302,000.00
  • BYON $1,476,271,000.00
  • Revenue This Year
  • LUNG $22.26
  • BYON N/A
  • Revenue Next Year
  • LUNG $18.72
  • BYON $4.55
  • P/E Ratio
  • LUNG N/A
  • BYON N/A
  • Revenue Growth
  • LUNG 22.34
  • BYON N/A
  • 52 Week Low
  • LUNG $5.46
  • BYON $4.45
  • 52 Week High
  • LUNG $14.84
  • BYON $37.10
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.35
  • BYON 53.20
  • Support Level
  • LUNG $6.24
  • BYON $5.55
  • Resistance Level
  • LUNG $7.27
  • BYON $6.35
  • Average True Range (ATR)
  • LUNG 0.39
  • BYON 0.51
  • MACD
  • LUNG -0.06
  • BYON 0.08
  • Stochastic Oscillator
  • LUNG 2.52
  • BYON 62.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: